Harvard Bioscience
HBIO
HBIO
71 hedge funds and large institutions have $74.7M invested in Harvard Bioscience in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Holders
71
Holding in Top 10
1
Calls
$18K
Puts
–
Top Buyers
| 1 | +$4.98M | |
| 2 | +$2.82M | |
| 3 | +$2.61M | |
| 4 |
HP
Harvey Partners
Tarrytown,
New York
|
+$2.28M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.31M |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$1.44M | |
| 3 | -$1.3M | |
| 4 |
Renaissance Technologies
New York
|
-$1.19M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$1.18M |